On Monday, Exact Sciences Corp. (NASDAQ: EXAS) opened lower -0.12% from the last session, before settling in for the closing price of $58.85. Price fluctuations for EXAS have ranged from $56.05 to $100.77 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 43.88% over the past five years. Company’s average yearly earnings per share was noted 20.56% at the time writing. With a float of $179.65 million, this company’s outstanding shares have now reached $181.36 million.
Let’s look at the performance matrix of the company that is accounted for 6600 employees.
Exact Sciences Corp. (EXAS) Insider Updates
A key investor’s attitude towards the stock of the Diagnostics & Research industry is another important factor to consider. The insider ownership of Exact Sciences Corp. is 1.04%, while institutional ownership is 87.66%. The most recent insider transaction that took place on Apr 02 ’24, was worth 73,393. In this transaction EVP, GM., Precision Oncology of this company sold 924 shares at a rate of $79.43, taking the stock ownership to the 13,171 shares. Before that another transaction happened on Apr 01 ’24, when Company’s EVP, Human Resources sold 2,000 for $70.00, making the entire transaction worth $140,000. This insider now owns 71,787 shares in total.
Exact Sciences Corp. (EXAS) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 20.56% per share during the next fiscal year.
Exact Sciences Corp. (NASDAQ: EXAS) Trading Performance Indicators
Check out the current performance indicators for Exact Sciences Corp. (EXAS). In the past quarter, the stock posted a quick ratio of 2.07. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.27. Likewise, its price to free cash flow for the trailing twelve months is 334.18.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.14, a number that is poised to hit -0.48 in the next quarter and is forecasted to reach 0.13 in one year’s time.
Technical Analysis of Exact Sciences Corp. (EXAS)
Exact Sciences Corp. (NASDAQ: EXAS) saw its 5-day average volume 1.98 million, a negative change from its year-to-date volume of 2.29 million. As of the previous 9 days, the stock’s Stochastic %D was 4.28%. Additionally, its Average True Range was 2.98.
During the past 100 days, Exact Sciences Corp.’s (EXAS) raw stochastic average was set at 11.58%, which indicates a significant increase from 2.47% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 47.11% in the past 14 days, which was higher than the 45.86% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $63.23, while its 200-day Moving Average is $69.91. Nevertheless, the first resistance level for the watch stands at $59.87 in the near term. At $60.95, the stock is likely to face the second major resistance level. The third major resistance level sits at $61.58. If the price goes on to break the first support level at $58.16, it is likely to go to the next support level at $57.53. Assuming the price breaks the second support level, the third support level stands at $56.45.
Exact Sciences Corp. (NASDAQ: EXAS) Key Stats
There are currently 181,531K shares outstanding in the company with a market cap of 10.67 billion. Presently, the company’s annual sales total 2,500 M according to its annual income of -204,150 K. Last quarter, the company’s sales amounted to 646,890 K and its income totaled -49,770 K.
